“…It has been shown in in vitro, in vivo and clinical studies that antioxidants activate the NO/eNOS pathway through decreasing in the amount of ROS [ 56 , 57 , 58 ]. Several lines of evidence have shown that antioxidants including vitamin E [ 59 , 60 , 61 , 62 ], vitamin B12 [ 63 ], alpha-lipoic acid [ 62 ], N-acethlcystein [ 64 , 65 ], flaxseed [ 66 ], L-carnitine [ 67 ], catechins [ 68 ], coenzyme Q10 [ 69 ], pycnogenol [ 70 ], and chlorogenic acids [ 71 ] improve or augment endothelial function in patients with CVD and in subjects who have cardiovascular risk factors as well as healthy subjects. However, not all of the studies showed the beneficial effects of antioxidants on endothelial function [ 72 , 73 , 74 , 75 , 76 ].…”